Dear Catherine,
Join advocates from across the country in asking your elected officials to cosponsor the CLINICAL TREATMENT Act.
Clinical trials are a promising avenue for expanding treatment options and extending survival for people with cancer. However, steep out-of-pocket costs associated with trial participation and gaps in insurance coverage create barriers for many cancer patients. Medicaid insures one-fifth of the US population and is the only major health care insurer that is not required by federal law to cover routine costs associated with participation in clinical trials.
The CLINICAL TREATMENT Act (H.R. 913 and S. 4742) would fix this, bringing Medicaid in line with federal requirements for clinical trials coverage in Medicare and private health insurance. This legislation guarantees coverage of the routine care costs of clinical trial participation for Medicaid enrollees regardless of their state of residence.
Please lend your voice to this important issue by writing to your Representative and Senators asking them to cosponsor the CLINICAL TREATMENT Act.
Robust clinical trial participation improves the quality of medical research. Increased access to clinical trial participation for Medicaid enrollees helps ensure medical research results more accurately capture and reflect the populations of this country.
Take action today and make your voice heard!
Sincerely,
Elizabeth Franklin, PhD, MSW
Executive Director, Cancer Policy Institute
|
Cancer Support Community
“So that No One Faces Cancer Alone”
734 15th Street NW | Suite 300
Washington, DC 20005
No comments:
Post a Comment